Company Filing History:
Years Active: 1987-1991
Title: Roy L. Hopfer: Innovator in Liposomal Treatments for Fungal Infections
Introduction
Roy L. Hopfer is a notable inventor based in Houston, TX (US), recognized for his contributions to the field of medical treatments, particularly in the area of fungal infections. He holds a total of 4 patents, showcasing his innovative approach to addressing significant health challenges.
Latest Patents
Among his latest patents, one significant invention is the "Liposome-incorporated mepartricin." This invention involves a liposomal agent designed for treating disseminated fungal infections in animals. The liposomal agent comprises the polyene antifungal compound mepartricin, which is encapsulated within a stable multilamellar vesicle. The liposome is formulated with various lipids, including phosphomonoglyceride, phosphatidic acid, and sphingolipid, with a preference for phosphatidylcholine and phosphatidylglycerol. The method of treatment involves administering a fungicidally effective amount of mepartricin encapsulated within a liposome, which can be delivered parenterally, orally, or topically, depending on the specific fungal infection.
Another notable patent is the "Composition and method for treatment of disseminated fungal infections." This method involves administering a fungicidally effective amount of Amphotericin B encapsulated in a substantially sterol-free liposome to infected mammals. This innovative approach aims to enhance the effectiveness of the treatment while minimizing potential side effects associated with sterols.
Career Highlights
Roy L. Hopfer is affiliated with the University of Texas System, where he continues to contribute to research and development in medical treatments. His work focuses on creating effective solutions for combating fungal infections, which pose significant health risks to both humans and animals.
Collaborations
Throughout his career, Roy has collaborated with esteemed colleagues such as Gabriel Lopez-Berestein and Reeta Mehta. These collaborations have further enriched his research and development efforts, leading to advancements in the treatment of fungal infections.
Conclusion
Roy L. Hopfer's innovative work in liposomal treatments for fungal infections highlights his commitment to improving health outcomes through scientific research. His patents reflect a significant contribution to the medical field, particularly in the treatment of challenging infections.